Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites
Related Experiment Video
Updated: Aug 8, 2026
Capturing Common Fragile Site Breaks by Native γH2A.X ChIP
Published on: January 24, 2025
S G Durkin1, M F Arlt, N G Howlett
1Department of Human Genetics, University of Michigan, Ann Arbor, MI 48109, USA.
Abstract:
Common fragile sites are specific regions of the genome that form gaps and breaks on metaphase chromosomes when DNA synthesis is partially inhibited. Fragile sites and their associated genes show frequent deletions and other rearrangements in cancer cells, and may be indicators of DNA replication stress early in tumorigenesis. We have previously shown that the DNA damage response proteins ATR, BRCA1 and FANCD2 play critical roles in maintaining the stability of fragile site regions. To further elucidate the pathways regulating fragile site stability, we have investigated the effects of depletion of the cell cycle checkpoint kinases, CHK1 and CHK2 on common fragile site stability in human cells. We demonstrate that both CHK1 and CHK2 are activated following treatment of cells with low doses of aphidicolin that induce fragile site breakage. Furthermore, we show that depletion of CHK1, but not CHK2, using short-interfering RNA (siRNA) leads to highly destabilized chromosomes and specific common fragile site breakage. In many cells, CHK1 depletion resulted in extensive chromosome fragmentation, which was distinct from endonucleolytic cleavage commonly associated with apoptosis. These findings demonstrate a critical role for the CHK1 kinase in regulating chromosome stability, and in particular, common fragile site stability.
Insights
The study reveals that CHK1 kinase is crucial for maintaining chromosome stability, particularly at common fragile sites. Depleting CHK1 causes significant chromosome breakage and fragmentation, highlighting its role in preventing DNA replication stress during tumorigenesis.
Area of Science:
- Genetics
- Molecular Biology
- Cell Biology
Background:
- Common fragile sites are genome regions prone to breakage during DNA replication stress.
- These sites are frequently altered in cancer, suggesting a link to early tumorigenesis.
- DNA damage response proteins like ATR, BRCA1, and FANCD2 are known to stabilize fragile sites.
Purpose of the Study:
- To investigate the role of cell cycle checkpoint kinases CHK1 and CHK2 in maintaining common fragile site stability.
- To determine if CHK1 and CHK2 activation is involved in the response to DNA replication stress at fragile sites.
Main Methods:
- Human cells were treated with aphidicolin to induce fragile site breakage.
- Activation of CHK1 and CHK2 was assessed after aphidicolin treatment.
- Short-interfering RNA (siRNA) was used to deplete CHK1 and CHK2.
- Chromosome stability and fragile site breakage were analyzed in depleted cells.
Main Results:
- Both CHK1 and CHK2 were activated by low-dose aphidicolin, indicating their involvement in the DNA replication stress response.
- Depletion of CHK1, but not CHK2, led to significant chromosome destabilization and specific common fragile site breakage.
- CHK1 depletion caused extensive chromosome fragmentation, distinct from apoptosis-associated cleavage.
Conclusions:
- CHK1 kinase plays a critical role in maintaining the stability of common fragile sites.
- The findings highlight CHK1's importance in preventing genomic instability associated with DNA replication stress and potentially early cancer development.
Related Concept Videos
02:36DNA Damage can Stall the Cell Cycle
02:36DNA Damage Can Stall the Cell Cycle
02:37Restarting Stalled Replication Forks
02:04Fixing Double-strand Breaks
02:04Fixing Double-strand Breaks
02:19The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...